Bar Admissions

  • Maryland


  • J.D., cum laude, University of Maryland School of Law, 2006
  • B.A., cum laude, Gettysburg College, 2002
T +1 410.244.7576
F +1 410.244.7742

William F. Herrfeldt


Bill Herrfeldt is a member of Venable's Corporate Practice Group and represents established large and middle market companies, start-up and emerging growth companies, private funds, institutional investors and financial institutions in all manner of corporate transactions. Specific experience includes mergers and acquisitions, structured equity and debt transactions, strategic partnering and joint ventures, private equity and venture capital transactions, commercial loan transactions, fundraising and investment fund formation (including co-investment arrangements and syndications), technology transfers, licensing and general corporate planning.

Bill has significant debt and servicing right purchase experience, including representing bank and non-bank purchasers of distressed and performing credit card receivables, mortgage loan portfolios, auto loan portfolios and servicing rights from originators, intermediaries and receivers.

He also represents investors and developers in real estate joint ventures for commercial, industrial and multifamily projects.

Bill has specific experience representing investors, fund syndicators, sponsors and developers in structuring and negotiating tax credit transactions, including syndicated and single-investor federal and state tax credit equity funds.

He serves as outside general counsel for many closely held businesses.

Significant Matters

Bill's experience includes representing:
  • Guthy-Renker LLC in the 2016 sale of a majority interest of its worldwide Proactiv business, the world's leading non prescription acne brand, to NestlĂ© Skin Health
  • One of the largest housing products distributors in North America in multiple strategic acquisitions and acquisition financing transactions.
  • Bowles Fluidics Corporation in its sale by merger to Morgenthaler Private Equity.
  • Public pension funds and other institutional investors in private equity and hedge fund investments ranging in size between $10 million and $200 million.
  • Real estate private equity funds and investment advisors in numerous joint ventures established to fund and govern the acquisition and development of commercial, industrial and multifamily properties throughout the United States.
  • Technology staffing company in a $60 million purchase of an international staffing business with operations in four countries.
  • Private equity fund in connection with the purchase of an industrial division of Textron Inc. that included 34 companies located in 17 countries with a total transaction value in excess of $1.1 billion.
  • Distressed debt fund in a $20 million revolving credit facility secured by multiple tranches of healthcare receivables that included complex cash-recycling components and the acquisition of multiple portfolios of credit card, subprime auto and healthcare receivables.
  • Major privately-held coal company in the stock acquisitions of two competitors for a combined purchase price of $66 million and a joint venture with a major publicly-held energy company valued between $400 million and $900 million.
  • Investors in over 30 multi-investor and single-investor federal low-income housing tax credit equity funds with an average investment between $8 million and $50 million.
  • Tax credit fund syndicator in structuring its first multi-investor fund offering.
  • Regional petroleum jobber in the acquisition of all the assets of a major Mid-Atlantic jobber and gas station owner for a total transaction value in excess of $26 million.
  • National licensed sporting goods retailer in the sale of all its assets to a major publicly-held retailer for a total transaction value in excess of $34 million.
  • Mortgage loan servicer in the acquisition of multiple portfolios of mortgage servicing rights, including the acquisition of a portfolio of $5.2 billion UPB of mortgage servicing rights relating to Ginnie Mae guaranteed MBS for approximately $24 million.


Bill's civic participation includes the Board of Directors of the Crohn's and Colitis Foundation of America, Maryland/S. Delaware Chapter.